Here in the United States, prostate cancer is the second most diagnosed cancer in men, behind only skin cancer. Almost 13% of ...

For many men with prostate cancer, the word “radiotherapy” still conjures up weeks of daily hospital trips: 20 or more ...

An expert on prostate cancer gives a brief overview of castrate-resistant prostate cancer. This is a synopsis of an Educated Patient Sound Bites series featuring Alicia Morgans, MD, MPH, of ...

Both are effective but work in slightly different ways: The newer of the two, lutetium-177, which was approved by the U.S. Food and Drug Administration (FDA) in 2022, can treat cancer that has ...

One in eight men will be diagnosed with prostate cancer—and if you live long enough, chances of an enlarged prostate skyrocket. Experts weigh in on what you need to know. Hormonal changes in a man's ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

The metastatic prostate cancer market is undergoing a major transition from conventional ADT toward combination-based, biomarker-driven, and precision-targeted treatment approaches. While AR pathway ...

Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy ...

Conference MDAngle offers personal perspectives from conference attendees, showcasing their anticipation, quick takeaways, and insights into how the presented research will affect their patients.

Note: While research on alcohol is evolving, the Centers for Disease Control and Prevention says drinking less or not at all is better for your health. Alcohol is part of many people’s social lives, ...

Prostate cancer starts in the prostate, a small gland located below the bladder that is responsible for secreting one of the components of semen. Prostate cells may grow out of control and become ...

If you or a loved one has prostate cancer, you may be interested in learning about medicines used to treat it. One option is a medicine called Erleada (apalutamide). The FDA approved Erleada in 2018.